Michelle Le Beau, MS, PhD
Professor of Medicine, University of Chicago and director, University of Chicago Medicine Comprehensive Cancer Center
Michelle Le Beau has been the director of the company since 2019. Dr. Le Beau holds numerous positions at the University of Chicago, including Arthur and Marian Edelstein Professor of Medicine, Section of Hematology/Oncology since 1986; Director, Cancer Cytogenetics Laboratory since 1986; Director, University of Chicago Medicine Comprehensive Cancer Center since 2004; Board Member of the University of Chicago Medicine Cancer Council since 2012.
Dr. Le Beau holds a PhD and an M.S. in human genetics and experimental pathology from the University of Illinois at Chicago and a B.S. from Purdue University, and is board-certified in clinical cytogenetics by the American Board of Medical Genetics and Genomics.
Nominating and Corporate Governance Committee
Ethics and Compliance Committee